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PMaximizing Patient Benefit From
Cardiac Resynchronization Therapy With
the Addition of Structured Exercise Training
A Randomized Controlled Study
Ashish Y. Patwala, MB CHB,* Paul R. Woods, PHD,† Lisa Sharp, PHD,† David F. Goldspink, DSC,†
Lip B. Tan, PHD,‡ David J. Wright, MD*
Liverpool and Leeds, United Kingdom
Objectives We evaluated the benefits of additional exercise training after cardiac resynchronization therapy (CRT).
Background Cardiac resynchronization therapy results in improved morbidity and mortality in appropriate patients. We
hypothesized that a structured exercise training program in addition to CRT would maximize the improvements
in exercise capacity, symptoms, and quality of life (QOL).
Methods Fifty patients referred for CRT were recruited. Patients were assessed before and 3 and 6 months after CRT.
Functional class and QOL scores were recorded, and exercise tests were performed with hemodynamic measure-
ments. Peak lower limb skeletal muscle torque was measured during extension, and echocardiography was un-
dertaken at each visit. At 3 months, patients were randomized with a simple sealed envelope method to exer-
cise training (n  25) or control group (n  25). The exercise group underwent an exercise program consisting
of 3 visits/week for 3 months. Paired sample t tests were used to look for in-group differences and independent
sample t tests for between-group differences.
Results Three months after CRT there were significant improvements in all functional, exercise hemodynamic, and echo-
cardiographic measures. After randomization the exercise group showed further significant improvements in
functional, exercise hemodynamic, and QOL measures compared with the control group. There were also signifi-
cant in-group improvements in peak skeletal muscle function and ejection fraction that did not reach statistical
significance on intergroup analysis.
Conclusions Exercise training leads to further improvements in exercise capacity, hemodynamic measures, and QOL in addi-
tion to the improvements seen after CRT. Therefore, exercise training allows maximal benefit to be attained af-
ter CRT. (J Am Coll Cardiol 2009;53:2332–9) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.063l
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“hronic heart failure (CHF) is an increasingly common
ondition. In suitable patients cardiac resynchronization
herapy (CRT) leads to an improvement in exercise capac-
ty, functional class, peak oxygen consumption (VO2),
emodynamic measures, and quality of life (QOL) scores
1,2). More recently a significant improvement in mortality
as also been demonstrated (3). These benefits primarily
ccur due to an improvement in the central cardiovascular
unction of the heart. The improvement in cardiac function
rom the *Liverpool Heart and Chest Hospital, Liverpool, United Kingdom;
RISES, Liverpool John Moores University, Liverpool, United Kingdom; and the
Academic Unit of Molecular Vascular Medicine, University of Leeds, Leeds, United
ingdom. Dr. Tan has been an invited lecturer for and received educational
ponsorship from pacemaker manufacturers. Dr. Wright has given educational
ectures on behalf of Medtronic and Boston Scientific.i
Manuscript received November 24, 2008; revised manuscript received February 17,
009, accepted February 24, 2009.eads to reverse remodeling with a reduction in the left
entricular size and an improvement in the ejection fraction
EF) (4). However, despite these improvements, all of the
ajor trials have demonstrated a 20% to 30% nonresponder
ate. This might reflect poor lead placement due to limited
enous anatomy, poor pacing parameters due to proximity
See page 2340
f myocardial damage, or diaphragmatic stimulation. We
ostulate that the nonresponder rate might also reflect the
act that CRT only improves the central hemodynamic
tatus of the patient and a significant proportion of patient
ymptoms are due to peripheral factors.
Recognition of peripheral abnormalities has led to the
muscle hypothesis of cardiac failure.” This proposes that
nadequate skeletal muscle perfusion generates symptoms
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June 23, 2009:2332–9 Benefits of Exercise Training After CRTnd, via muscle ergoreceptors, leads to increased neurohor-
onal activation, peripheral vasoconstriction, and therefore
isease progression (5). It is now widely accepted that in
atients with chronic heart failure a period of exercise
raining can lead to improvements in exercise capacity, peak
O2, QOL, and in 1 trial, mortality (6,7). The mechanism
ehind the improvement in peak VO2 is likely to be a
ombined improvement in central cardiac output and pe-
ipheral oxygen extraction. However, the majority of trials
valuating exercise training have focused on patients with mild
eart failure (New York Heart Association [NYHA] func-
ional class I to II). Most recently the HF-ACTION (Heart
ailure and A Controlled Trial Investigating Outcomes of
xercise Training) trial showed that exercise training was
afe in patients with more severe heart failure (NYHA
unctional class II to IV) and led to an improvement in peak
O2. Despite this there were no significant improvements
n mortality or morbidity in this group (8). Patients suitable
or CRT are of a comparable functional status to those in
he HF-ACTION trial. The combination of exercise train-
ng and CRT has not been well-investigated, with only 1
mall-scale study suggesting possible benefit (9).
Our hypothesis was that patients suitable for CRT would
emonstrate both central and peripheral decompensation
ue to a prolonged inability to exercise. Although CRT
ould improve cardiac output and exercise capacity, it
ould not necessarily improve skeletal muscle performance.
herefore, we hypothesized that exercise training in addi-
ion to CRT would lead to further improvements in peak
O2 by improving skeletal muscle performance.
ethods
atient population. Fifty patients awaiting CRT at our
enter between July 2004 and June 2006 were invited to
articipate in this study. Standard clinical guidelines were
sed to assess suitability for CRT (10). All patients were in
YHA functional class III to IV. All patients were receiv-
ng optimal medical therapy for CHF and had been in a
table condition for more than 1 month (no hospital stay for
eart failure, no change in medication, and no change in
YHA functional class). All had a QRS width 120 ms
nd a left ventricular EF 35%. Exclusion criteria included
oncardiac physical limitation (e.g., arthritis, pulmonary
isease, myocardial infarction within the last 3 months),
oronary artery bypass grafting or percutaneous transluminal
oronary angioplasty within the last 3 months or planned for
he future, and significant untreated valvular heart disease.
he study was approved by the Liverpool local research
thics committee, and informed written consent was ob-
ained from all patients.
tudy protocol. All patients underwent cardiopulmonary
xercise testing, a resting transthoracic echocardiogram,
OL assessment with the Minnesota Living With Heart
ailure (MLWHF) questionnaire, and measurement of
eak skeletal muscle torque during extension. All measure- dents were taken at baseline and
epeated 3 and 6 months after
RT. Before the study a separate
amiliarization test was per-
ormed and the results discarded.
After the 3-month assessment
atients were randomized (as de-
cribed in the following text) into
ither an exercise group (n  25)
r a control group (n  25). The
xercise group underwent a pro-
ram of physician-supervised exer-
ise training consisting of 3 30-
in visits/week. Each session
onsisted of 10 min treadmill
alking followed by 10 min cy-
ling and then a further 10 min
readmill walking. The intensity
as 80% of the peak heart rate
HR) achieved at the 3-month
est for the first 4 weeks, 85% for
he next 4 weeks, and 90% for
he final 4 weeks. This was per-
ormed at a nonclinical setting
Liverpool John Moores University) away from the base
ospital. Patients were supervised by an advanced life
upport-trained physician not involved in the CRT implant
r follow-up at the base hospital (Liverpool Heart and
hest Hospital). Clinical follow-up was organized at the
ase hospital for both groups. The exercise group was not
rovided with any specific instruction or guidance to per-
orm exercise outside of the study. The control group was
iven no specific advice on exercise training and underwent
o supervised training. No change in cardiac medication
ccurred as part of the study protocol.
andomization. Randomization occurred at 3 months. It
as not performed at baseline, to eliminate the potential for
ias due to pre-emptive training in the exercise group.
andomization was performed with a simple sealed enve-
ope method. Fifty sealed envelopes, 25 with exercise
raining and 25 with control, were placed into a box. After
he 3-month assessment for each patient, an envelope was
icked by a person not involved in the study.
ardiopulmonary exercise tests. These were conducted as
escribed in previous reports (11,12). Exercise testing was
onducted over 2 consecutive days. On the first day resting
ardiac output (CO) was measured with the carbon dioxide
CO2) rebreathing technique of Collier (13) and calculated
ith the indirect Fick method. The concentrations of gases in
he rebreathe mixture were 10% CO2, 35% O2, and 55%
itrogen, and the volume was twice that of the subject’s resting
idal volume. Before each CO measurement systolic and
iastolic blood pressure were measured with a manual sphyg-
omanometer. Mean arterial pressure (MAP) was calculated
rom the standard equation: MAP (systolic pressure 2
Abbreviations
and Acronyms
CHF  chronic heart failure
CO  cardiac output
CPO  cardiac power
output
CRT  cardiac
resynchronization therapy
EF  ejection fraction
HR  heart rate
LVEDD  left ventricular
end diastolic dimension
MAP  mean arterial
pressure
MLWHF  Minnesota
Living with Heart Failure
NYHA  New York Heart
Association
QOL  quality of life
RER  respiratory
exchange ratio
VO2  oxygen consumptioniastolic pressure)/3 (14). Mean CORest and MAPRest were
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Benefits of Exercise Training After CRT June 23, 2009:2332–9alculated from triplicate measurements, separated by 4 min to
llow for CO2 washout from the circulation.
After this a symptom-limited incremental exercise test
as performed on a Cosmos treadmill (Cosmos, Nussdorf-
raustein, Germany) with the modified Bruce protocol to
easure the VO2, peak CO2 production, respiratory ex-
hange ratio (RER), HR, and exercise duration, with the
edGraphics CPX/D system (Medical Graphics Corpora-
ion, St. Paul, Minnesota). At peak exercise blood pressure
as measured, a CO2 rebreathing maneuver was performed
o determine peak CO with the Defares (15) method, and
as concentrations of 5% CO2, 35% O2, and 60% nitrogen
ere employed. Ventilatory anaerobic threshold was calcu-
ated with the V-slope method. On the second day a second
xercise test was performed to the same VO2 and peak CO2
roduction as on the first day. At peak exercise a second
eak CO measurement was made with the aforementioned
rotocol. The 2 peak CO measurements were averaged to
btain a mean COPeak. Cardiac power output (CPO) was
alculated at rest and peak exercise from the averaged CO
l/min) and MAP (mm Hg) with the formula:
CPOCO  MAP  K
here K is the conversion factor (2.22  103) into Watts.
chocardiography. A resting transthoracic echocardio-
ram was performed at each visit after the patient had been
esting for a minimum of 30 min. Left ventricular end-
iastolic dimension (LVEDD) was measured in the
arasternal long axis view. Ejection fraction was measured
ith the biplane Simpson’s method via the apical 4- and
-chamber views.
sokinetic dynamometry. Skeletal muscle function was
ssessed in both legs during 2 sets of 5 knee extensions at
0°/s with a Biodex isokinetic dynamometer. Testing was
erformed after a minimum of 30 min rest.
mplantation and programming of atrio-biventricular
acemaker. Implantation was performed according to
tandard technique of atrio-biventricular pacemaker im-
lantation. The pacemaker was programmed to a base rate
f 60 beats/min and the upper limit 85% of the age–sex
aximum predicted HR. Atrioventricular delays were pro-
rammed to standard settings (120 ms paced, 100 ms
ensed). No V-V offset was used during this study. Biven-
ricular VVIR pacemakers were implanted in patients with
trial fibrillation. For the purposes of this study patients in
trial fibrillation did not undergo atrioventricular node
blation before or during the study period. Patients received
RT-P and CRT-D devices as appropriate, and no distinc-
ion was made between them.
tatistical analysis. All continuous variables are presented
s mean  SD. Discrete variables are presented as modes.
or in-group analyses paired sample t tests were used to
ook for statistical significance in continuous variables, and
hi-square tests were used for discrete variables. To look for
ifferences between the exercise and control groups at 6
A
Honths, change scores were calculated and independent
ample t tests were used. Analyses were carried out with
PSS version 12.0.1 for Windows (SPSS Inc., Chicago,
llinois). Statistical significance was set at the 5% level.
esults
aseline data. At baseline the mean age was 64.4 years
ith a 92% male preponderance. Patients had a mode
YHA functional class of 3 and a mean peak VO2 of 16.12
ls/kg/min. Mean electrocardiographic QRS duration was
60 ms, and echocardiography provided a mean LVEDD of
.07 cm with an EF of 24.0%. Thirty-three of the 50
ubjects were in sinus rhythm (66%). Patients were well-
edicated at baseline. Full baseline data is shown in Table 1.
hree months after CRT. Results from baseline and 3
onths are seen in Table 2. There was a significant increase
n peak VO2 from 16.12  3.44 mls/min/kg to 18.41 
.56 mls/min/kg (p  0.001). There were also significant
mprovements in NYHA functional classification from a
ode of 3 to 2 (chi-square p 0.001) and exercise duration
rom 374  188 s to 562  220 s (p  0.001).
During this period there were also significant improve-
ents in exercise hemodynamic measures. Peak CPO in-
reased from 2.48 0.79 W to 3.20 0.78 W (p 0.001),
nd cardiac reserve improved from 1.85  0.68 W to 2.54
0.70 W (p  0.001). The maximum RER achieved
mproved from 1.00  0.12 to 1.08  0.09 (p  0.001);
owever, the percentage of peak VO2 at the anaerobic
hreshold remained unchanged at this point (71.8  17.2%
s. 69.1  8.9%; p  0.319).
Echocardiographic measures showed a significant reduc-
ion in the LVEDD (7.07  0.87 cm vs. 6.64  0.77 cm;
 0.001) and an increase in the EF from 23.7  8.7% to
2.4 6.2% (p 0.001). Quality of life, as measured by the
LWHF score, also improved significantly (61.8 17.7 to
1.8  19.5; p  0.001).
Peak skeletal muscle function (Newton Meters [N-M])
howed no significant change in either leg at 3 months.
aseline Data (N  50)
Table 1 Baseline Data (N  50)
Age (yrs) 64.4
Sex (% male) 92
NYHA functional class 3
Peak VO2 (mls/kg/min) 16.12
QRS width (ms) 160.4
Left ventricular end-diastolic diameter (cm) 7.07
Ejection fraction (%) 23.67
Sinus rhythm (%) 66
Atrial fibrillation (%) 34
ACE inhibitors or ARBs 98
Beta blockers 60
Digoxin 46
Spironolactone 54
Loop diuretic 96CE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; NYHA  New York
eart Association; VO2  oxygen consumption.
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June 23, 2009:2332–9 Benefits of Exercise Training After CRTAt 3 months the patients were randomized to either
xercise training or control. The 2 groups were well-
atched at the point of randomization. There were no
ignificant differences in any variables as seen in Table 3.
ix months after CRT. After randomization the exercise
roup showed a further significant improvement in peak
O2 (18.74  3.40 mls/kg/min vs. 20.10  3.84 mls/kg/
in; p  0.011) (Fig. 1), NYHA functional class (2 vs. 1;
 0.001) (Fig. 2), exercise duration (581  226 s vs. 752
179 s; p  0.001), and MLWHF score (34.6  22.3 vs.
6.2  20.5; p  0.013). The control group showed a
ignificant improvement in exercise duration (542  215 s
s. 572  220 s; p  0.028) but no improvements in peak
O2, NYHA functional class, or MLWHF score. Inter-
roup analyses confirmed that the improvements in NYHA
unctional class (mean change exercise: 1 vs. control: 0; p 
aseline to 3 Months Results
Table 2 Baseline to 3 Months Results
Before CRT
3 Months
After CRT
NYHA functional class 3 2*
Exercise duration (s) 374 188 562 220*
Peak VO2 (mls/kg/min) 16.12 3.44 18.41 3.56*
Peak cardiac power output (W) 2.48 0.79 3.20 0.78*
Cardiac reserve (W) 1.85 0.68 2.54 0.70*
Respiratory exchange ratio 1.00 0.12 1.08 0.09*
Percentage of peak VO2 at the anaerobic
threshold (%)
71.8 17.2 69.1 8.9
Left ventricular end-diastolic dimension (cm) 7.07 0.87 6.64 0.77*
Ejection fraction (%) 23.7 8.7 32.4 6.2*
Right extension (N-M) 128.3 46.2 131.3 48.9
Left extension (N-M) 124.1 46.1 127.2 45.8
Minnesota Living With Heart Failure score 61.8 17.7 31.8 19.5*
p  0.05 compared with baseline.
CRT  cardiac resynchronization therapy; N-M  Newton Meters; NYHA  New York Heart
ssociation; VO2  oxygen consumption.
xercise and Hemodynamic Results After Randomization
Table 3 Exercise and Hemodynamic Results After Randomizati
Exercise Group
3 Months 6 Months
NYHA functional class 2 1*
Exercise duration (s) 581 226 752 179*
Peak VO2 (mls/kg/min) 18.74 3.40 20.10 3.84*
Peak cardiac power output (W) 3.27 0.82 3.76 1.01*
Cardiac reserve (W) 2.57 0.72 3.05 0.93*
Respiratory exchange ratio 1.10 0.09 1.14 0.08*
Percentage of peak VO2 at the
anaerobic threshold (%)
67.5 8.3 62.1 10.0*
Left ventricular end-diastolic
dimension (cm)
6.64 0.89 6.40 0.53
Ejection fraction (%) 32.8 6.2 37.3 5.4*
Right extension (N-M) 135.0 50.3 144.8 57.6*
Left extension (N-M) 135.0 50.4 143.6 53.1*
Minnesota Living With Heart
Failure score
34.6 22.3 26.2 20.5*p  0.05 compared with 3 months; †p  0.05 compared with control group  change.
Abbreviations as in Table 2..001), exercise duration (mean change exercise: 171 
74 s vs. control: 30  64 s; p  0.001), peak VO2 (mean
hange exercise: 1.37  2.49 mls/kg/min vs. control: 0.01
1.49 mls/kg/min; p  0.022), and MLWHF scores
mean change exercise:8.4 15.6 vs. control: 1.6 15.3;
 0.026) were significantly better in the exercise group.
Peak CPO (3.27  0.82 W vs. 3.76  1.01 W; p 
.001) and cardiac reserve (2.57  0.72 W vs. 3.05  0.93
; p  0.001) were both improved in the exercise group
lone. The maximum RER achievable was significantly
ncreased in the exercise group (1.10 0.09 vs. 1.14 0.08;
 0.001), and there was a significant reduction in the
ercentage of peak VO2 at the anaerobic threshold (67.5 
.3% vs. 62.1  10.0%; p  0.010) (Fig. 3). The control
roup showed no change during the same period. Inter-
roup analysis confirmed that the improvement in peak
PO (mean change exercise: 0.49  0.61 W vs. control:
.06  0.64 W; p  0.019), cardiac reserve (mean change
xercise: 0.48  0.57 W vs. control: 0.01  0.63 W; p 
.008), and RER (mean change exercise: 0.04  0.06 vs.
ontrol:0.01 0.07; p 0.008) were significantly greater
n the exercise group. There was a trend toward a difference
etween the 2 groups when assessing the change in the
ercentage of peak VO2 at the anaerobic threshold, but this
id not reach significance (mean change exercise: 5.4 
.7% vs. control: 0.8  10.3%; p  0.109).
At 6 months the exercise group showed a trend toward an
mprovement in LVEDD, but this did not reach statistical
ignificance (6.64  0.89 cm vs. 6.40  0.53 cm; p 
.164). The improvement in the control group did achieve
ignificance (6.57  0.56 cm vs. 6.34  0.57 cm; p 
.006). Conversely the EF significantly improved in the
xercise group (32.8  6.2% vs. 37.3  5.4%; p  0.010)
ut not in the control group (32.6  7.0% vs. 35.0  7.2%;
Control Group
 Change 3 Months 6 Months  Change
1† 2 2 0
71 174† 542 215 572 220* 30 64
.37 2.49† 18.08 3.75 18.07 3.89 0.01 1.49
.49 0.61† 3.14 0.76 3.20 0.96 0.06 0.64
.48 0.57† 2.51 0.69 2.52 0.88 0.01 0.63
.04 0.06† 1.07 0.07 1.06 0.10 0.01 0.07
5.4 9.7 70.8 9.4 70.0 11.3 0.8 10.3
.20 0.74 6.57 0.56 6.34 0.57* 0.23 0.38
4.5 8.2 32.6 7.0 35.0 7.2 2.5 8.0
9.8 17.1 127.7 48.2 131.5 49.5 3.8 9.7
8.7 13.8 119.4 40.2 124.3 40.8 5.0 11.8
8.4 15.6† 29.0 16.3 29.5 17.8 1.6 15.3on
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Benefits of Exercise Training After CRT June 23, 2009:2332–9 0.132). Intergroup analyses of the changes showed no
ignificant difference between the 2 groups in either
VEDD (mean change exercise: 0.20  0.74 cm vs.
ontrol: 0.23  0.38 cm; p  0.963) or EF (mean change
xercise: 4.5  8.2% vs. control: 2.5  8.0%; p  0.371).
After the period of exercise training the peak skeletal
uscle torque during extension (N-M) was significantly
mproved in the exercise group (right: 135.0  50.3 vs.
44.8  57.6; p  0.009; left: 135.0  50.4 vs. 143.6 
3.1; p  0.004). The control group showed no significant
hange during this period. Intergroup analyses showed no
ignificant difference between the 2 groups in either right-
ided extension (N-M) (mean change exercise: 9.8  17.1
s. control: 3.8  9.7; p  0.133) or left-sided extension
Figure 1 Peak Oxygen Consumption
*p  0.05 compared to baseline; †p  0.05 compared to 3 months.
Figure 2 New York Heart Association Functional Class
*p  0.05 compared to baseline; †p  0.05 compared to 3 months.N-M) (mean change exercise: 8.7 13.8 vs. control: 5.0
1.8; p  0.309).
No patients in the exercise group had any complications
rom the exercise training, and there were no problems with
ardiac arrhythmias. Full results are given in Table 3.
iscussion
hree months after CRT we demonstrated significant
mprovements in all functional and hemodynamic measures.
hese improvements were of a similar magnitude and over
similar time scale as those seen in other multicenter trials
16,17). At 3 months there was a 14% improvement in the
eak VO2 and an approximately 30% improvement in the
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June 23, 2009:2332–9 Benefits of Exercise Training After CRTeak CPO and cardiac reserve. Ejection fraction also
howed a 37% improvement. In addition to these improve-
ents the MLWHF score improved by almost 50%. The
aseline peak VO2 was 16.12 mls/kg/min, which is slightly
igher than has previously been reported in CRT trials
1,18). However, the correlation between peak VO2 and
YHA functional class is known to be poor (19). Peak VO2
howed a significant improvement at 3 months without a
ignificant change in the percentage of VO2 at the anaerobic
hreshold. This suggests that the improvement in peak VO2
as due to an equal improvement in the capacity to perform
erobic and anaerobic exercise. After CRT the increased
ER reflects an ability to exercise to a greater level of
hysiological stress. This was not a familiarization response
ecause a separate exercise test had been performed before
he study and the results discarded. The results at 3 months
upport the theory that CRT improves function due to
nhanced central cardiac function alone. Our study confirms
he absence of any peripheral skeletal muscle changes 3
onths after CRT alone.
At the point of randomization there were no significant
ifferences between the 2 groups. Randomization was de-
ayed until the 3-month stage, to limit bias. Had patients
een aware at an earlier stage that they were going to be in
he exercise group, there would have been the potential for
hem to self train. This would have influenced the 3-month
esults and made any comparison between the 2 groups less
eliable. The exercise training group underwent a graduated
ntensity exercise program over 3 months, whereas the
ontrol group was given no specific advice relating to
xercise. We recognize that this exercise training program
as more intensive than the usual cardiac rehabilitation
ffered to patients after myocardial infarction or coronary
evascularization. Previous trials looking at exercise in CHF
Figure 3 Percentage of Peak Oxygen Consumption at the Anae
†p  0.05 compared to 3 months.ave had varying intensity and frequency. In the ExTra- pATCH (Exercise Training Meta-Analysis of Trials in
atients With Chronic Heart Failure) meta-analyses, the
rials varied from 2 to 7 times/week and 50% to 80% of
he peak HR (7), and in the HF-ACTION trial the
xercise program was 30 min 3 times/week in the
upervised stage. However, by the end of the trial the
verage duration of exercise was only 50 min/week (8).
ecause our trial was based over a 3-month training
eriod, it was necessary to have a higher intensity of
xercise. Hence we started at 80% and went up to 90% of
eak HR. Despite the high intensity it was well tolerated
nd no patients in the exercise group had any complica-
ions from the exercise training.
At 6 months, those patients undertaking exercise training
emonstrated further significant improvements in NYHA
unctional class, exercise time, peak VO2, peak CPO,
ardiac reserve, RER, and MLWHF score that were not
irrored in the control group. Although in-group analysis
howed a significant improvement in skeletal muscle func-
ion with exercise training, this was not supported by
ignificant intergroup changes compared with the control
roup. This might reflect the relatively small number of
atients in each group. It might equally be due to the
requency or duration of the training program. Had the
atients exercised more frequently or for a longer period, the
ifferences in improvement in peak skeletal muscle function
ight have achieved significance. Nevertheless the overall
hanges at the end of the study were greater in the exercise
roup for most variables (Fig. 4). The overall improvement
n exercise duration seen in the control group (53%) was
omparable to previously published data (18). However, the
ntroduction of exercise training increased the improvement
o 101%. This level of improvement has never been de-
cribed after CRT alone. Peak VO2, known as a powerful
Thresholdrobicredictor of prognosis (20), was improved by 12% in the
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gain, this level of improvement has never previously been
eported. In all hemodynamic measures the addition of
xercise training doubled the percentage improvement at 6
onths when compared with the control group. The
xercise group also showed more substantial improvements
n both right- (13%) and left-sided (16%) peak skeletal
uscle function. The control group showed only a 2.4%
mprovement in right-sided and a 0.2% improvement in
eft-sided extension during the same period.
The likely explanation behind these overall changes is
hat CRT alone improves functional capacity and QOL by
nhancing cardiac function, and exercise training improves
unctional capacity further by enhancing skeletal muscle and
ardiac function.
tudy limitations. This study used a randomized, con-
rolled protocol. A further control group suitable for CRT
ut randomized to exercise training alone would have
mproved the methodology. However, in view of the
ARE-HF (Cardiac Resynchronization-Heart Failure)
tudy (8)—which showed a mortality benefit from CRT—it
as considered unethical to withhold CRT even tempo-
arily. Overall the dataset was relatively small, and therefore
ome caution should be exerted when interpreting the
esults. However, all of the principle measures achieved
ighly significant improvements. In view of the relatively
mall number of patients involved in this study, it was not
Figure 4 Percentage Change at 6 Months
AT  anaerobic threshold; CPO  cardiac power output; CR  cardiac reserve; EF 
MLWHF  Minnesota Living with Heart Failure; NYHA  New York Heart Associppropriate to look for benefits in mortality or CHF tospital stay. These end points could only be accurately
ssessed by larger-scale trials.
By the very nature of exercise training, it is impossible
o blind the patient to whether they are in the exercise or
ontrol group. We attempted to limit any potential
mpact by delaying randomization until the 3 month
tage. We also tried to minimize bias from actual training
isits in the exercise training group by performing the
xercise training in a nonclinical setting and by using a
hysician not involved in the pacemaker implant or
ollow up.
linical implications of this study. In view of the signif-
cantly improved outcomes in the exercise group, it would be
easonable to suggest that exercise training should be offered
o all patients after CRT. This would ensure the best
ossible outcome from CRT. The exercise program used in
his study was a practical regimen that could be used in
linical practice.
onclusions
RT is an effective treatment for suitable patients. The
ddition of exercise training significantly enhances the
enefits seen by improving both the central cardiac function
nd the peripheral skeletal muscle function. Exercise train-
ng would provide only a small additional cost to the overall
ost of CRT, and therefore we feel that it would be justified
n fraction; LVEDD  left ventricular end diastolic dimension;
RER  respiratory exchange ratio; VO2  oxygen consumption.ejectio
ation;o offer this to all patients after CRT.
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